Acrivon Therapeutics, Inc. (ACRV)
1.63
+0.05
(+3.16%)
USD |
NASDAQ |
Feb 13, 16:00
1.65
+0.02
(+1.23%)
After-Hours: 20:00
Acrivon Therapeutics EPS Diluted (Quarterly) : -0.4729 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aclarion, Inc. | -2.930 |
| Humacyte, Inc. | -0.1106 |
| PMGC Holdings, Inc. | -19.64 |
| Aspire Biopharma Holdings, Inc. | -1.494 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.23M |
| Total Expenses (Quarterly) | 18.23M |
| Enterprise Value | -74.83M |
| Earnings Yield | -130.6% |
| Normalized Earnings Yield | -130.63 |